Observational studyCancer chemotherapy and pharmacology2021

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.

Maria Spiliotaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.